Urinary apolipoprotein (a) excretion in patients with proteinuria

References

• Berg K, Dahlen G, Frick M H. Lp(a) lipoprotein and pre-β1-lipoprotein in patients with coronary heart disease. Clin Genet 1974; 6: 230–5
   PubMed Web of Science ®Google Scholar
• Kostner G M, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Qunici G B. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981; 38: 51–61
   PubMed Web of Science ®Google Scholar
• Armstrong V W, Cremer P, Eberle E, et al. The associaton between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 1986; 62: 249–57
   PubMed Web of Science ®Google Scholar
• Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyana M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Dependence on serum LDL levels. Atherosclerosis 1986; 59: 199–204
   PubMed Web of Science ®Google Scholar
• Cushing G L, Gaubatz J W, Nava M L, et al. Quantitation and localization of apolipoproteins (a) and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis 1989; 9: 593–603
   PubMedGoogle Scholar
• Cremer P, Nagel D, Labrot B, et al. Lipoprotein(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS). Eur] Clin Invest 1994; 24: 444–53
   PubMed Web of Science ®Google Scholar
• McLean J W, Tomlinson J E, Kuang W J, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 330: 132–7
   PubMed Web of Science ®Google Scholar
• Edelberg J M, Pizzo S V. Lipoprotein(a) inhibits plasminogen activation in a template-dependent manner. Blood Coagul Fibrinolysis 1991; 2: 759–64
   PubMed Web of Science ®Google Scholar
• Bihari-Varga M, Gruber E, Rothencder M, Zechner R, Kostner G M. Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis 1988; 8: 851–7
   PubMedGoogle Scholar
• Krempler F, Kostner G M, Bolzano K, Sandhofer F. Turnover of lipoprotein (a) in man. J Clin Invest 1980; 65: 1483–90
   PubMed Web of Science ®Google Scholar
• Parra H J, Mezdour H, Cachera C, Dracon M, Tacquet A, Fruchart J C. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clin Chem 1987; 33: 721
   PubMed Web of Science ®Google Scholar
• Karadi I, Romics L, Palos G, et al. Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin. Clin Cbem 1989; 35: 2121–3
   PubMed Web of Science ®Google Scholar
• Faucher C, Doucet C, Baumelou A, Chapman J, Jacobs C, Thillet J. Elevated lipoprotein(a) levels in primary nephrotic syn-drome. Am J Kidney Dis 1993; 22: 808–13
   PubMed Web of Science ®Google Scholar
• Thomas M E, Freestone A, Varghese Z, Persaud J W, Moorhead J F. Lipoprotein(a) in patients with proteinuria. Nephrol Dial Transplant 1992; 7: 597–601
   PubMed Web of Science ®Google Scholar
• Ordonez J D, Hiatt R A, Killebrew E J, Fireman B H. The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int 1993; 44: 638–42
   PubMed Web of Science ®Google Scholar
• Appel G B, Blum C B, Chien S, Kunis C L, Appel A S. The hyperlipidemia of nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity. N Engl J Med 1985; 312: 1544–8
   PubMed Web of Science ®Google Scholar
• Oida K, Takai H, Maeda H, et al. Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure. Clin Chem 1992; 38: 2244–8
   PubMed Web of Science ®Google Scholar
• Kostner K, Maurer G, Huber K, et al. Urinary excretion of apo(a) fragments. Role in apo(a) catabolism. Atherioscler Thromh Vase Biol 1996; 16: 905–11
   PubMed Web of Science ®Google Scholar
• Utermann G, Menzel H J, Kraft H G, Duba H C, Kemmler H G, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987; 80: 458–65
   PubMed Web of Science ®Google Scholar
• Kostner K M, Oberbauer R, Hoffmann U, Stefenelli T, Maurer G, Watschinger B. Urinary excretion of apo(a) in patients after kidney transplantation. Nephrol Dial Transpl 1997; 12: 2673–8
   PubMed Web of Science ®Google Scholar
• Kronenberg F, Utermann G, Dieplinger H. Lipoprotein(a) in renal disease. Am J Kidney Dis 1996; 27: 1–25
   PubMed Web of Science ®Google Scholar
• Mooser V, Seabra M C, Abedin M, Landschulz K T, Marcovina S, Hobbs H H. Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a). J Clin Invest 1996; 97: 858–64
   PubMed Web of Science ®Google Scholar
• Kostner K, Jansen M, Maurer G, Derfler K. LDL-apheresis significantly reduces urinary apo(a) excretion. Eur J Clin Invest 1997; 27: 93–5
   PubMed Web of Science ®Google Scholar
• Scherberich J E. Urinary proteins of tubular origin: basic immunochemical and clinical aspects. Am J Nephrol 1990; 10(Suppl 1)43–51
   PubMed Web of Science ®Google Scholar